ALLK (allakos.com) Sof foyda

ALLK (allakos.com) - kompaniyaning tovar belgisi

GURU.Markets grafigidagi Allakos Inc. kompaniyasining marginal daromadi foyda dinamikasini namoyish etadi, bunda -0.07 qiymati eng so'nggi ko'rsatkichni ifodalaydi. Allakos Inc. bozor ulushini egallash uchun yallig'lanishga qarshi lireltelimab qo'llanilishini kengaytirishni maqsad qilgan. Noyob Siglec-8 blokirovka qilish usuli og'ir allergiyalarni davolashga yordam beradi. Firma hozirda o'zining immunologik ishlanmalari klinik sinovlarini mustaqil ravishda o'tkazmoqda.

ALLK (Allakos Inc.) Sof foyda tarixi 04.07.2022dan 24.05.2025gacha

allakos.com (ALLK) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Allakos|ALLK - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi ALLK|ALLK - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Allakos|ALLK - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi allakos.com|ALLK - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Allakos Inc.|ALLK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Allakos|ALLK - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ALLK|ALLK - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Allakos|Shoshilinch likvidlik allakos.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ALLK - Sof foyda
Kompaniyaning jamlanma tahlili:Allakos Inc.
Allakos Inc asosiy tovari

Allakos Inc. yallig'lanish jarayonlarini davolash uchun innovatsion antitanalarni ishlab chiqishga ixtisoslashgan bo'lib, bu yerda kapitalni boshqarish samaradorligi klinik muvaffaqiyatga bevosita ta'sir qiladi. Kompaniyaning foyda ko'rsatkichlarini tahlil qilish orqali investor operatsion daromad bo'yicha bozor konsensusini ko'rishi mumkin, bu esa fundamental voqealarga bozorning joriy kayfiyatini aks ettiradi va barqaror pul oqimini xavfli narx pufakchalardan ajratish imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|UPB (upstreambio.com) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|Sof foyda pieris.com PVLA|SVRA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Rigel Pharma|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|ATXS - Sof moliyaviy natija|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof foyda JBIO|Sof moliyaviy natija Aclaris Therapeutics Inc.|Kompaniyaning sof foydasi Kyverna KYTX|TLSA: Kompaniya foydasi|Cabaletta Bio, Inc. - Sof foyda|ventyxbio.com (VTYX) - Sof daromad|THTX (Theratechnologies) - Sof daromad|AVTX - Sof moliyaviy natija|ELDN (Eledon) - Sof foyda|Sof foyda Agenus, Inc|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|Kompaniyaning sof foydasi ZURA (zurabio.com)|Kompaniyaning sof foydasi aTyr Pharma ATYR|Adagene Inc - Kompaniyaning sof foydasi|IMA - Kompaniyaning sof foydasi|STTK - Sof foyda|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Sof foyda|ATRA: Yakuniy foyda|Sof foyda IFRX|Sof foyda X4 Pharmaceuticals, Inc (XFOR)|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Yakuniy foyda CELU|INMB - Kompaniyaning sof foydasi|Barinthus Biotherapeutics PLC (BRNS) - Sof daromad|KZR: Sof foyda|SAB Biotherapeutics Inc (SABS) - Sof foyda|Sof daromad AKTX|ENLV: Yakuniy foyda|Sof foyda QTTB|Sof moliyaviy natija GeoVax Labs|Kompaniyaning sof foydasi Edesa EDSA|IBIO - Sof daromad|CARM - Kompaniyaning sof foydasi|xtlbio.com (XTLB) - Sof daromad|BOLT (boltbio.com) - Sof daromad|HCW Biologics (HCWB) - Sof foyda|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|Kompaniya foydasi AIM (aimimmuno.com)|Sof foyda ADTX|GRI - Kompaniyaning sof daromadi|Sof foyda XRTX (XORTX Therapeutics)|Sof foyda Vyome Holdings Inc. HIND|REVB - Kompaniyaning sof foydasi|INDP: Kompaniyaning sof foydasi|Scinai Immunotherapeutics (SCNI) - Kompaniyaning sof foydasi|CALI (CalciMedica) - Kompaniyaning sof foydasi|AFMD (Affimed NV) - Sof foyda|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|THRD - Kompaniyaning sof foydasi